The C-Terminus of Tfpiα Inhibits Factor V Activation By Protecting the Arg1545 Cleavage Site

被引：0
|
作者：
van Doorn, Peter [1 ]
Rosing, Jan [1 ]
Wielders, Simone [1 ]
Hackeng, Tilman M. [1 ]
Castoldi, Elisabetta [1 ]
机构：
[1] Maastricht Univ, Cardiovascular Res Inst Maastricht, Dept Biochem, Maastricht, Netherlands
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.257.257
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
257
引用
收藏
页数：5
相关论文
共 45 条
  • [1] The C-terminus of tissue factor pathway inhibitor- inhibits factor V activation by protecting the Arg1545 cleavage site
    van Doorn, P.
    Rosing, J.
    Wielders, S. J.
    Hackeng, T. M.
    Castoldi, E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (01) : 140 - 149
  • [2] The C-terminus of tissue factor pathway inhibitor-a inhibits factor V activation by protecting the Arg1545 cleavage site (vol 15, pg 140, 2017)
    van Doorn, P.
    Rosing, J.
    Wielders, S. J.
    Hackeng, T. M.
    Castoldi, E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2019, 17 (07) : 1195 - 1195
  • [3] Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding
    Camire, RM
    Kalafatis, M
    Tracy, PB
    BIOCHEMISTRY, 1998, 37 (34) : 11896 - 11906
  • [4] Development of a Plasma-Based Assay to Measure the Susceptibility of Factor V to Inhibition by the C-Terminus of TFPIα
    van Doorn, Peter
    Rosing, Jan
    Campello, Elena
    Middeldorp, Saskia
    Simioni, Paolo
    Meijers, Joost C. M.
    Hackeng, Tilman M.
    Castoldi, Elisabetta
    THROMBOSIS AND HAEMOSTASIS, 2020, 120 (01) : 55 - 64
  • [5] ENZYMATIC CLEAVAGE AT THE C-TERMINUS OF TISSUE FACTOR PATHWAY INHIBITOR
    NORDFANG, O
    VALENTIN, S
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 613 - 613
  • [6] Cleavage at Arg(1545) on human factor V is necessary for optimum factor Xa binding in prothrombinase.
    Kalafatis, M
    Henderson, SC
    Camire, RM
    Hassan, MI
    Mann, KG
    BLOOD, 1995, 86 (10) : 281 - 281
  • [7] EVIDENCE THAT THE C-TERMINUS OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) IS ESSENTIAL FOR ITS INTERACTION WITH LIPOPROTEINS
    WILDGOOSE, P
    VALENTIN, S
    NORDFANG, O
    CIRCULATION, 1992, 86 (04) : 815 - 815
  • [8] Cleavage at Arg1018 is not required for factor V activation
    Na, M.
    Wiencek, J. R.
    Hirbawi, J.
    Kalafatis, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 472 - 472
  • [9] Proteolysis of factor V by cathepsin G indicates that cleavage at Arg(1545) optimizes factor Va cofactor activity in prothrombinase
    Camire, RM
    Kalafatis, M
    Tracy, PB
    THROMBOSIS AND HAEMOSTASIS, 1997, : OC244 - OC244
  • [10] The C-terminus of tissue factor pathway inhibitor (TFPI) modulates triglyceride metabolism by enhancing the activity of lipoprotein lipase (LPL)
    Mukherjee, M
    Kakkar, VV
    THROMBOSIS AND HAEMOSTASIS, 1997, : P1661 - P1661
12345